Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Alliance Pharma PLC (GB:APH)
LSE:APH
Alliance Pharma (APH) Share Price & Analysis
4 Followers
APH Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range33.75p - 118.66p
Previous Close60.6p
Volume705.02K
Average Volume (3M)2.29M
Market Cap
£327.32M
Enterprise Value43.32B
Total Cash (Recent Filing)£31.71M
Total Debt (Recent Filing)£137.58M
Price to Earnings (P/E)356.5
Beta0.88
Next Earnings
Sep 19, 2023EPS Estimate
£0.02Next Dividend Ex-Date
Jun 22, 2023Dividend Yield
0.02 (0.03%)Share Statistics
EPS (TTM)<0.01
Shares Outstanding539,995,086
10 Day Avg. Volume921,555
30 Day Avg. Volume2,292,877
Standard Deviation0.08
R-Squared0.14
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)-247.89
Price to Sales (P/S)275.53
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
89.25pPrice Target Upside47.28% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
APH FAQ
What was Alliance Pharma PLC’s price range in the past 12 months?
Alliance Pharma PLC lowest share price was 33.75p and its highest was 118.66p in the past 12 months.
What is Alliance Pharma PLC’s market cap?
Currently, no data Available
When is Alliance Pharma PLC’s upcoming earnings report date?
Alliance Pharma PLC’s upcoming earnings report date is Sep 19, 2023 which is in 105 days.
How were Alliance Pharma PLC’s earnings last quarter?
Alliance Pharma PLC released its earnings results on Mar 21, 2023. The company reported -0.022p earnings per share for the quarter, missing the consensus estimate of 0.015p by -0.037p.
Is Alliance Pharma PLC overvalued?
According to Wall Street analysts Alliance Pharma PLC’s price is currently Undervalued.
Does Alliance Pharma PLC pay dividends?
Alliance Pharma PLC pays a Annually dividend of 1.18p which represents an annual dividend yield of 2.81%. See more information on Alliance Pharma PLC dividends here
What is Alliance Pharma PLC’s EPS estimate?
Alliance Pharma PLC’s EPS estimate is £0.02.
How many shares outstanding does Alliance Pharma PLC have?
Alliance Pharma PLC has 540,139,470 shares outstanding.
What happened to Alliance Pharma PLC’s price movement after its last earnings report?
Alliance Pharma PLC reported an EPS of -0.022p in its last earnings report, missing expectations of 0.015p. Following the earnings report the stock price went up 1.389%.
Which hedge fund is a major shareholder of Alliance Pharma PLC?
Currently, no hedge funds are holding shares in GB:APH
---
Alliance Pharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-46.36%
12-Months-Change
Fundamentals
Return on Equity
0.33%
Trailing 12-Months
Asset Growth
6.74%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Alliance Pharma PLC
Alliance Pharma PLC is a player in the healthcare market. The company's business includes acquisition, marketing, and distribution of pharmaceutical products. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol.
---
Top 5 ETFs holding APH
UBS (Irl) ETF Plc-MSCI United Kingdom IMI Socially Responsible GBP
$408.54K
UBS (Irl) ETF Plc - MSCI United Kingdom IMI Socially Responsible UCITS ETF EUR
$408.54K
UBS (Irl) ETF Plc-MSCI United Kingdom IMI Socially Responsible CHF
$408.54K
Up to five ETFs with an Outperform Smart Score that hold APH. The ETFs are listed according to market value of APH within the ETF
---
Futura Medical
―
Medica Group plc
―
HUTCHMED (China) Limited
―
Inspiration Healthcare
―
---